Il-17 Levels in Intrahepatic Cholestasis of Pregnancy
NCT01898832 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2014-03-18
Summary
The aim of this study is to investigate maternal and fetal serum IL-17 levels in pregnant women with intrahepatic cholestasis of pregnancy and to find out if Th-17 cells have a role in progress of intrahepatic cholestasis of pregnancy.
Conditions
- Intrahepatic Cholestasis of Pregnancy
Sponsors & Collaborators
-
Zekai Tahir Burak Women's Health Research and Education Hospital
lead OTHER
Principal Investigators
-
ayse kirbas, md · Zekai Tahir Burak Women's Health Research and Education Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 39 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-07-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Changes in Natural Immunity in Pregnant Women With Autoimmune Thyroid Disease
NCT06925399 ·Status: NOT_YET_RECRUITING
-
The Role of Sodium Chloride and the Treg/Th17 Axis in Autoimmune Hepatitis
NCT02050646 ·Status: COMPLETED ·Phase: NA
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Immun Status at Pancreatitis Patients
NCT03937323 ·Status: COMPLETED
-
Obstetrical History and Anti-HLA Antibodies Level
NCT06021925 ·Status: RECRUITING
-
UCB Cimzia Pregnancy Follow-up Study
NCT02775656 ·Status: TERMINATED
-
Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
NCT00499434 ·Status: UNKNOWN
-
Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
NCT02778464 ·Status: COMPLETED
-
ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis B
NCT01633554 ·Status: UNKNOWN
-
Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple Therapy
NCT02877199 ·Status: COMPLETED
-
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation
NCT00701272 ·Status: UNKNOWN
-
Hepatitis C Virus in Neutrophil Granulocyte Progenitor Cells
NCT02545387 ·Status: WITHDRAWN
-
A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
NCT04163016 ·Status: COMPLETED ·Phase: PHASE1
-
Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients
NCT06865859 ·Status: RECRUITING
-
THE RELATIONSHIP OF CRP/ALBUMIN RATIO LEVEL AND PROGNOSIS IN PREGNANT COVID-19 PATIENTS
NCT05242172 ·Status: UNKNOWN
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
NCT00160940 ·Status: UNKNOWN
-
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
NCT03178630 ·Status: RECRUITING
-
Protective Immune Mechanisms in Alcoholic Hepatitis
NCT01918462 ·Status: COMPLETED
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
Autoimmune Hepatitis Study
NCT00286663 ·Status: TERMINATED
-
Association Between Hidradenitis Suppurativa and Spondyloarthritis
NCT03668925 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis
NCT03693586 ·Status: COMPLETED
-
Genetic Polymorphisms of Interleukin-10 and TNF-α on Outcome of HCV-Related Chronic Liver Disease
NCT00630006 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C
NCT00638144 ·Status: UNKNOWN